GO:0062013 positive regulation of small molecule metabolic process: Metabolic Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0062013 describes any biological process that activates or increases the frequency, rate, or extent of a small molecule metabolic process, a broad regulatory node in metabolism.
• Small molecule metabolic processes include amino acid, lipid, nucleotide, and redox metabolism; their positive regulation is often mediated by nutrient sensors, transcription factors, and post-translational modifications.
• Dysregulation of positive regulation of small molecule metabolic processes contributes to cancer, neurodegeneration, and metabolic disorders, making it a target for therapeutic intervention.
• Key genes such as GPX4, ATF3, and ZDHHC8 illustrate how palmitoylation and transcriptional control can positively regulate small molecule metabolism and influence ferroptosis.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential to dissect causal roles of regulators within this GO term.
• EDITGENE provides end-to-end CRISPR services to study GO:0062013-related genes, from library screening to bioinformatics, accelerating mechanistic and translational research.
Description
GO:0062013, positive regulation of small molecule metabolic process, is a Gene Ontology biological process term that captures any mechanism that increases the rate, frequency, or extent of small molecule metabolism. Small molecules are low-molecular-weight compounds such as amino acids, lipids, nucleotides, and redox-active species that participate in countless cellular reactions. Understanding how these processes are positively regulated is fundamental to cell biology, as it links nutrient availability, signaling, and stress responses to metabolic output. Research into GO:0062013 has revealed that positive regulation can occur at multiple levels, including transcriptional activation, post-translational modification of enzymes, and allosteric control. For example, palmitoylation of GPX4 by ZDHHC8 enhances its activity and influences ferroptosis sensitivity, a form of regulated cell death dependent on small molecule metabolism. Similarly, ATF3 promotes erastin-induced ferroptosis by suppressing system Xc-, thereby altering small molecule redox metabolism. These findings underscore the importance of positive regulation in both normal physiology and disease. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0062013, covering its definition, mechanisms, key genes, disease relevance, and experimental methods. It is designed for researchers seeking to understand or manipulate this process using CRISPR-based models and advanced screening technologies.
positive regulation of small molecule metabolic process At A Glance
| GO ID | GO:0062013 |
|---|---|
| GO term | positive regulation of small molecule metabolic process |
| Ontology | biological_process |
| Synonym | positive regulation of small molecule metabolism |
| Definition | Any process that activates or increases the frequency, rate or extent of a small molecule metabolic process. |
| Major function | Upregulation of biochemical pathways involving small molecules, including amino acid, lipid, nucleotide, and redox metabolism. |
| Related processes | Ferroptosis, oxidative stress response, nutrient sensing, and metabolic reprogramming. |
| Key regulators | GPX4, ATF3, ZDHHC8, and other enzymes and transcription factors. |
| Disease relevance | Cancer, neurodegeneration, metabolic disorders, and ferroptosis-related pathologies. |
What Is GO:0062013?
According to the Gene Ontology, GO:0062013 (positive regulation of small molecule metabolic process) is defined as any process that activates or increases the frequency, rate, or extent of a small molecule metabolic process. In other words, it encompasses all molecular events that upregulate the biochemical reactions involving small molecules, such as amino acids, lipids, nucleotides, and redox compounds. This term is a biological process and is synonymous with positive regulation of small molecule metabolism.
Why Is positive regulation of small molecule metabolic process Important in Cell Biology?
Positive regulation of small molecule metabolic processes is central to cellular adaptation and survival. It controls the flux through pathways that generate energy, maintain redox balance, and supply building blocks for macromolecules. Dysregulation of these regulatory mechanisms is implicated in a wide range of diseases, including cancer, where metabolic reprogramming supports rapid proliferation, and neurodegeneration, where oxidative stress and lipid peroxidation contribute to neuronal death. Understanding GO:0062013 therefore offers insights into fundamental biology and potential therapeutic targets.
• Controls metabolic flux to meet cellular energy and biosynthetic demands.
• Regulates redox homeostasis and protects against oxidative stress.
• Modulates ferroptosis, a form of regulated cell death with therapeutic potential in cancer.
• Influences cancer cell survival and proliferation through metabolic reprogramming.
• Contributes to neurodegeneration via lipid peroxidation and impaired small molecule metabolism.
• Provides targets for drug development, such as ZDHHC8 inhibitors.
• Essential for immune cell function and antitumor immunity.
• Helps understand nutrient sensing and metabolic disorders.
• Guides CRISPR-based functional genomics studies.
• Enables precision medicine approaches targeting metabolic vulnerabilities.
What Happens During positive regulation of small molecule metabolic process?
Initiation by Nutrient and Stress Signals
In simple terms: Cells sense nutrients and stress, which triggers signals to boost small molecule metabolism.
Positive regulation of small molecule metabolic processes often begins with cellular sensing of nutrients, energy status, or stress. For instance, ferroptosis, a form of cell death driven by iron-dependent lipid peroxidation, is initiated by erastin, which inhibits system Xc- and alters small molecule redox metabolism. This triggers a cascade that can be positively regulated by transcription factors such as ATF3, which promotes erastin-induced ferroptosis by suppressing system Xc-. Similarly, palmitoylation of GPX4 by ZDHHC8 enhances its activity, positively regulating the metabolism of lipid peroxides and determining ferroptosis sensitivity.
Transcriptional and Post-Translational Control
In simple terms: Genes and proteins are switched on or modified to increase metabolic enzyme activity.
Once initiated, positive regulation can be enforced at transcriptional and post-translational levels. ATF3 acts as a transcription factor that suppresses system Xc-, thereby increasing sensitivity to ferroptosis and modulating small molecule metabolism. Post-translational modifications, such as palmitoylation of GPX4 by ZDHHC8, directly enhance enzyme function and positively regulate the detoxification of lipid peroxides. These layers of control ensure that small molecule metabolic processes are finely tuned to cellular needs.
Amplification of Metabolic Flux
In simple terms: The activity of metabolic pathways is ramped up to produce more small molecules or consume them faster.
Positive regulation often results in increased flux through specific metabolic pathways. For example, enhanced GPX4 activity reduces lipid peroxides, shifting the balance away from ferroptosis. Conversely, suppression of system Xc- by ATF3 leads to decreased glutathione synthesis, increasing lipid peroxidation and promoting ferroptosis. These changes in flux are critical for determining cell fate under stress conditions.
Integration with Cell Death and Survival Pathways
In simple terms: The boosted metabolism is linked to decisions about whether the cell lives or dies.
The positive regulation of small molecule metabolic processes is tightly integrated with cell death and survival signaling. Ferroptosis, a regulated cell death modality, is directly influenced by the positive regulation of small molecule metabolism, particularly redox and lipid metabolism. GPX4 palmitoylation by ZDHHC8 enhances cell survival by preventing ferroptosis, while ATF3 promotes ferroptosis by suppressing system Xc-. Thus, this GO term sits at the crossroads of metabolic and cell death pathways.
Feedback and Homeostatic Control
In simple terms: The cell monitors the results and adjusts the process to maintain balance.
To prevent excessive or insufficient metabolic activity, positive regulation is subject to feedback mechanisms. Although specific feedback loops for GO:0062013 are not fully detailed in the cited literature, general principles of metabolic regulation suggest that products of small molecule metabolism can inhibit upstream steps. Understanding these feedback controls is essential for targeting the pathway therapeutically without disrupting homeostasis.
Key Genes Involved in GO:0062013 positive regulation of small molecule metabolic process
The following genes and proteins are key players in the positive regulation of small molecule metabolic processes, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GPX4 | Glutathione peroxidase that reduces lipid peroxides; palmitoylation by ZDHHC8 enhances activity | Central to ferroptosis regulation and small molecule redox metabolism |
| ZDHHC8 | Palmitoyltransferase that palmitoylates GPX4, increasing its activity | Targetable enzyme for modulating ferroptosis sensitivity and antitumor immunity |
| ATF3 | Transcription factor that suppresses system Xc-, promoting erastin-induced ferroptosis | Links stress response to small molecule metabolism and ferroptosis |
| SLC7A11 | Subunit of system Xc- that imports cystine for glutathione synthesis | Regulates redox balance and ferroptosis sensitivity |
| GCLC | Catalytic subunit of glutamate-cysteine ligase, rate-limiting for glutathione synthesis | Involved in small molecule antioxidant metabolism |
| GCLM | Modulatory subunit of glutamate-cysteine ligase | Modulates glutathione synthesis and redox homeostasis |
| ACSL4 | Acyl-CoA synthetase that promotes lipid peroxidation | Key driver of ferroptosis through small molecule lipid metabolism |
| LPCAT3 | Lysophosphatidylcholine acyltransferase that incorporates polyunsaturated fatty acids into membranes | Contributes to lipid peroxidation and ferroptosis |
| NFS1 | Cysteine desulfurase involved in iron-sulfur cluster biogenesis | Supports small molecule metabolism and redox balance |
| FSP1 | Ferroptosis suppressor protein 1 that regenerates CoQ10 | Regulates small molecule antioxidant metabolism |
| DHODH | Dihydroorotate dehydrogenase in pyrimidine synthesis | Links nucleotide metabolism to ferroptosis |
| GTP cyclohydrolase 1 | Enzyme in tetrahydrobiopterin synthesis | Small molecule metabolism affecting ferroptosis |
| Tucatinib | HER2 tyrosine kinase inhibitor (drug) | Approved therapy; not directly a gene but included for context of metabolic regulation |
| Dimdazenil | GABA-A receptor positive allosteric modulator (drug) | Approved therapy; context for small molecule metabolic effects |
| Pexidartinib | CSF1R inhibitor (drug) | Approved therapy; context for metabolic regulation |
| Asciminib | BCR-ABL1 inhibitor (drug) | Approved therapy; context for metabolic pathways |
| Zongertinib | HER2 inhibitor (drug) | Approved therapy; context for metabolic regulation |
How Is positive regulation of small molecule metabolic process Regulated?
The positive regulation of small molecule metabolic processes is controlled by diverse mechanisms, including nutrient sensing, transcriptional programs, and post-translational modifications. For instance, the palmitoylation of GPX4 by ZDHHC8 directly enhances its enzymatic activity, positively regulating lipid peroxide metabolism and influencing ferroptosis sensitivity. Transcriptional regulation by ATF3 suppresses system Xc-, thereby altering small molecule redox metabolism and promoting ferroptosis. These examples highlight how upstream signals converge on metabolic enzymes to modulate flux. Additionally, general metabolic regulators such as mTOR and AMPK are known to influence small molecule metabolism, though specific links to GO:0062013 require further study.
positive regulation of small molecule metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GPX4 | Ferroptosis, cancer, neurodegeneration | Knockout and point-mutation cell lines to assess ferroptosis sensitivity |
| ZDHHC8 | Cancer, antitumor immunity | Knockout and overexpression models to test palmitoylation inhibitors |
| ATF3 | Ferroptosis, cancer | Knockout and overexpression models to study erastin response |
| SLC7A11 | Ferroptosis, cancer | Knockout models to evaluate system Xc- function |
| ACSL4 | Ferroptosis, neurodegeneration | Knockout models to study lipid peroxidation |
Cancer and Ferroptosis
Positive regulation of small molecule metabolic processes is critically involved in cancer biology, particularly through ferroptosis. GPX4 palmitoylation by ZDHHC8 enhances its activity, protecting cancer cells from ferroptosis and promoting antitumor immunity. Targeting ZDHHC8 could sensitize tumors to ferroptosis, offering a therapeutic strategy. ATF3 promotes erastin-induced ferroptosis by suppressing system Xc-, suggesting that modulating this pathway could be exploited in cancers resistant to conventional therapies. Thus, GO:0062013 represents a nexus of metabolic and cell death pathways in cancer.
Neurodegeneration
Dysregulation of small molecule metabolism and ferroptosis contributes to neurodegenerative diseases such as Alzheimer's and Parkinson's, where lipid peroxidation and oxidative stress lead to neuronal loss. Positive regulators of small molecule metabolic processes, including GPX4, play protective roles by detoxifying lipid peroxides. Understanding how these processes are upregulated could inform neuroprotective strategies.
Metabolic Disorders
Alterations in small molecule metabolic regulation are associated with metabolic disorders like diabetes and obesity, where nutrient sensing and flux control are impaired. Although direct evidence linking GO:0062013 to these conditions is limited, the term provides a framework for studying how positive regulation of amino acid, lipid, and nucleotide metabolism affects disease progression.
From positive regulation of small molecule metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GPX4 palmitoylation affect ferroptosis sensitivity? | Point-mutation knock-in of GPX4 at palmitoylation sites |
| What is the role of ZDHHC8 in antitumor immunity? | ZDHHC8 knockout and overexpression cell lines |
| How does ATF3 regulate system Xc- and ferroptosis? | ATF3 knockout and overexpression models |
| Is SLC7A11 required for cystine import and glutathione synthesis? | SLC7A11 knockout cells |
| Can ACSL4 inhibition protect against lipid peroxidation? | ACSL4 knockout and point-mutation models |
| What genes positively regulate small molecule metabolism? | CRISPR library screening with metabolic readouts |
How to Study the positive regulation of small molecule metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality and metabolic regulators | Identify positive regulators of small molecule metabolism |
| Metabolomics | Small molecule abundance and flux | Quantify metabolic changes |
| Palmitoylation assay | Protein palmitoylation status | Study GPX4 modification |
| Lipid peroxidation imaging | Lipid ROS levels | Assess ferroptosis |
| RNA-seq | Transcriptional changes | Identify ATF3 target genes |
| Western blot | Protein expression and modification | Validate knockout/overexpression |
| Cell viability assay | Cell survival | Measure ferroptosis sensitivity |
| CRISPR activation (CRISPRa) | Gene overexpression | Screen for positive regulators |
CRISPR Screening for Metabolic Regulators
Genome-wide CRISPR knockout or activation screens can identify genes that positively regulate small molecule metabolic processes. For example, screens for ferroptosis regulators have uncovered GPX4, ZDHHC8, and ATF3. These screens typically use metabolic readouts such as lipid peroxidation or cell viability under stress conditions.
Metabolomics and Flux Analysis
Mass spectrometry-based metabolomics quantifies small molecule levels and isotopic labeling to measure flux through metabolic pathways. This approach can reveal how positive regulators alter amino acid, lipid, and nucleotide metabolism.
Proteomics and Post-Translational Modification Analysis
Proteomic techniques, including palmitoylation assays, identify post-translational modifications that regulate enzyme activity. For instance, GPX4 palmitoylation by ZDHHC8 was discovered using such methods.
Imaging and Cell Death Assays
Live-cell imaging with fluorescent probes for lipid peroxidation (e.g., C11-BODIPY) and cell death assays (e.g., viability staining) are used to study ferroptosis and small molecule metabolism in real time.
How CRISPR Can Be Used to Study GO:0062013 positive regulation of small molecule metabolic process
Knockout
CRISPR knockout is used to delete genes such as GPX4, ZDHHC8, or ATF3 to determine their necessity in positive regulation of small molecule metabolic processes. For example, ZDHHC8 knockout reduces GPX4 palmitoylation and increases ferroptosis sensitivity. ATF3 knockout attenuates erastin-induced ferroptosis.
Point Mutation
Point mutations can be introduced to abrogate specific post-translational modification sites. For instance, mutating the palmitoylation sites on GPX4 prevents its modification by ZDHHC8, affecting ferroptosis regulation. This approach helps dissect the precise molecular mechanisms.
Knock-in
Knock-in of tagged or reporter versions of genes allows tracking of protein localization and interactions. For example, knocking in a fluorescent tag on GPX4 enables live-cell imaging of its distribution during ferroptosis.
Overexpression
CRISPR activation or cDNA overexpression is used to increase gene expression and assess sufficiency. Overexpressing ZDHHC8 enhances GPX4 palmitoylation and protects against ferroptosis. Overexpressing ATF3 promotes ferroptosis by suppressing system Xc-.
How EDITGENE Supports positive regulation of small molecule metabolic process Research
Researchers studying positive regulation of small molecule metabolic process-related genes often need to determine whether a candidate gene is causally involved in metabolic regulation, ferroptosis, or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of small molecule metabolic process research.
Frequently Asked Questions About positive regulation of small molecule metabolic process
What is GO:0062013?
GO:0062013 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate, or extent of a small molecule metabolic process.
What genes are involved in positive regulation of small molecule metabolic process?
Key genes include GPX4, ZDHHC8, ATF3, SLC7A11, and ACSL4, which regulate redox and lipid metabolism.
How is positive regulation of small molecule metabolic process related to ferroptosis?
Positive regulation can either promote or inhibit ferroptosis; for example, GPX4 palmitoylation by ZDHHC8 suppresses ferroptosis, while ATF3 promotes it.
What diseases are associated with GO:0062013?
Cancer, neurodegeneration, and metabolic disorders are linked to dysregulation of small molecule metabolism.
What experimental models are used to study GO:0062013?
CRISPR knockout, point mutation, knock-in, overexpression, and library screening models are commonly used.
How can CRISPR help study positive regulation of small molecule metabolic process?
CRISPR enables precise gene editing to test causality, identify regulators, and model disease-associated mutations.
What is the role of ZDHHC8 in small molecule metabolism?
ZDHHC8 palmitoylates GPX4, enhancing its activity and positively regulating lipid peroxide metabolism.
How does ATF3 regulate small molecule metabolism?
ATF3 suppresses system Xc-, reducing glutathione synthesis and promoting ferroptosis.
What methods measure small molecule metabolic flux?
Metabolomics, flux analysis, and lipid peroxidation imaging are key methods.
Why is positive regulation of small molecule metabolic process important for cancer therapy?
It influences ferroptosis sensitivity and antitumor immunity, offering targets like ZDHHC8 for therapeutic intervention.
Conclusion
GO:0062013, positive regulation of small molecule metabolic process, is a fundamental biological process that governs how cells upregulate small molecule metabolism in response to signals and stress. Key regulators such as GPX4, ZDHHC8, and ATF3 have been shown to modulate ferroptosis and redox homeostasis, with implications for cancer, neurodegeneration, and metabolic diseases. Understanding these mechanisms provides opportunities for therapeutic intervention and requires robust experimental models. EDITGENE offers comprehensive CRISPR services to support research in this field, from knockout and point mutation to library screening and bioinformatics.
References
- 1. Zhou L et al.. 2025. Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity.. Nat Cancer 6(5):768-785 PMID: 40108413
- 2. Xie Y et al.. 2016. Ferroptosis: process and function.. Cell Death Differ 23(3):369-79 PMID: 26794443
- 3. Wang L et al.. 2020. ATF3 promotes erastin-induced ferroptosis by suppressing system Xc().. Cell Death Differ 27(2):662-675 PMID: 31273299
- 4. Lee A. 2020. Tucatinib: First Approval.. Drugs 80(10):1033-1038 PMID: 32548668
- 5. Syed YY. 2024. Dimdazenil: First Approval.. Drugs 84(5):607-611 PMID: 38546956
- 6. Lamb YN. 2019. Pexidartinib: First Approval.. Drugs 79(16):1805-1812 PMID: 31602563
- 7. Deeks ED. 2022. Asciminib: First Approval.. Drugs 82(2):219-226 PMID: 35041175
- 8. Lee A. 2026. Zongertinib: First Approval.. Drugs 86(3):397-401 PMID: 41549172
